» Articles » PMID: 19347076

Measurement Properties of the Chinese Language Version of the Functional Assessment of Cancer Therapy-general in a Singaporean Population

Overview
Specialty General Medicine
Date 2009 Apr 7
PMID 19347076
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Health-related quality of life is an important aspect of health outcome. The assessment of it must be done by validated instruments. There is no published data on the validity, reliability and sensitiveness to change of the official Chinese translation of the Functional Assessment of Cancer Therapy-General (version 4; FACT-G).

Materials And Methods: A Chinese questionnaire package comprising the FACT-G and Functional Living Index-Cancer (FLIC, which was translated, modified and validated in Singapore) was filled in by 165 ethnic Chinese patients recruited from the National Cancer Centre, Singapore. Four weeks later, the patients were assessed again by a postal questionnaire survey.

Results: The FACT-G and FLIC total scores were strongly correlated (r = 0.85). The Physical, Social/Family, Emotional and Functional Well-being scales of the FACT-G converged to and diverged from FLIC components as conceptually expected. The FACT-G and its 4 scales also demonstrated known-groups validity in differentiating patients with different performance status (each P <0.001). Their internal consistency ranged from 0.81 to 0.93 and test-retest reliability ranged from 0.74 to 0.85. The FACT-G and its Physical, Emotional and Functional Well-being scales showed trends of change in relation to change in performance status. The Social/Family Well-being scale was sensitive to decline but not improvement in performance status.

Conclusions: The Chinese version of the FACT-G can be used to assess overall level and some specific aspects of health-related quality of life. However, researchers should be cautious in using this instrument to specifically investigate the social aspect of quality of life.

Citing Articles

Reverse Time-to-Death as Time-Scale in Time-to-Event Analysis for Studies of Advanced Illness and Palliative Care.

Cheung Y, Ma X, Chaudhry I, Liu N, Zhuang Q, Yang G Stat Med. 2025; 44(3-4):e10338.

PMID: 39846408 PMC: 11755714. DOI: 10.1002/sim.10338.


Assessment of the psychometric properties of the traditional Chinese version of the cancer survivors' self-efficacy scale.

Chien C, Chuang C, Wu C, Pang S, Liu K, Yu K Psicol Reflex Crit. 2024; 37(1):33.

PMID: 39177718 PMC: 11343950. DOI: 10.1186/s41155-024-00317-y.


Mobile App for Gynecologic Cancer Support for Patients With Gynecologic Cancer Receiving Chemotherapy in China: Multicenter Randomized Controlled Trial.

Lin H, Ye M, Lin Y, Chen F, Chan S, Cai H J Med Internet Res. 2023; 25:e49939.

PMID: 37955943 PMC: 10682921. DOI: 10.2196/49939.


The early predictive value of frailty for health-related quality of life among elderly patients with cancer receiving curative chemotherapy.

Hu Y, Chen S, Chou W, Chen J, Weng L, Tsay P PLoS One. 2023; 18(8):e0287320.

PMID: 37531395 PMC: 10395968. DOI: 10.1371/journal.pone.0287320.


Trajectories of Health-related quality of life in patients with Advanced Cancer during the Last Year of Life: findings from the COMPASS study.

Lee J, Shafiq M, Malhotra R, Ozdemir S, Teo I, Malhotra C BMC Palliat Care. 2022; 21(1):183.

PMID: 36242033 PMC: 9569120. DOI: 10.1186/s12904-022-01075-3.